First Trust Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,837
Closed -$420K 2523
2022
Q1
$420K Buy
+10,837
New +$420K ﹤0.01% 2298
2021
Q4
Sell
-45,618
Closed -$2.7M 2534
2021
Q3
$2.7M Sell
45,618
-13,925
-23% -$1.09M ﹤0.01% 1650
2021
Q2
$5.17M Sell
59,543
-13,665
-19% -$1.1M 0.01% 1339
2021
Q1
$6.04M Sell
73,208
-35,117
-32% -$3.36M 0.01% 1135
2020
Q4
$9.85M Buy
108,325
+41,427
+62% +$2.57M 0.01% 836
2020
Q3
$2.67M Sell
66,898
-13,881
-17% -$485K ﹤0.01% 1227
2020
Q2
$2.77M Sell
80,779
-20,357
-20% -$607K ﹤0.01% 1218
2020
Q1
$2.25M Buy
101,136
+80,566
+392% +$2.04M 0.01% 1216
2019
Q4
$403K Sell
20,570
-164,130
-89% -$2.61M ﹤0.01% 2187
2019
Q3
$2.87M Buy
184,700
+50,312
+37% +$964K 0.01% 1327
2019
Q2
$2.73M Buy
+134,388
New +$2.42M 0.01% 1388

Other funds holding FATE